BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21908579)

  • 1. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.
    Chen D; Yoo BK; Santhekadur PK; Gredler R; Bhutia SK; Das SK; Fuller C; Su ZZ; Fisher PB; Sarkar D
    Clin Cancer Res; 2011 Nov; 17(21):6693-701. PubMed ID: 21908579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma.
    Tomimaru Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M; Nagano H
    Int J Cancer; 2012 Jan; 130(2):319-27. PubMed ID: 21328580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).
    Srivastava J; Robertson CL; Gredler R; Siddiq A; Rajasekaran D; Akiel MA; Emdad L; Mas V; Mukhopadhyay ND; Fisher PB; Sarkar D
    J Biol Chem; 2015 Jun; 290(25):15549-15558. PubMed ID: 25944909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Akiel M; Guo C; Li X; Rajasekaran D; Mendoza RG; Robertson CL; Jariwala N; Yuan F; Subler MA; Windle J; Garcia DK; Lai Z; Chen HH; Chen Y; Giashuddin S; Fisher PB; Wang XY; Sarkar D
    Cancer Res; 2017 Aug; 77(15):4014-4025. PubMed ID: 28619711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.
    Srivastava J; Siddiq A; Emdad L; Santhekadur PK; Chen D; Gredler R; Shen XN; Robertson CL; Dumur CI; Hylemon PB; Mukhopadhyay ND; Bhere D; Shah K; Ahmad R; Giashuddin S; Stafflinger J; Subler MA; Windle JJ; Fisher PB; Sarkar D
    Hepatology; 2012 Nov; 56(5):1782-91. PubMed ID: 22689379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.
    Yoo BK; Emdad L; Su ZZ; Villanueva A; Chiang DY; Mukhopadhyay ND; Mills AS; Waxman S; Fisher RA; Llovet JM; Fisher PB; Sarkar D
    J Clin Invest; 2009 Mar; 119(3):465-77. PubMed ID: 19221438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
    Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.
    Tomimaru Y; Eguchi H; Wada H; Noda T; Murakami M; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Br J Cancer; 2010 May; 102(10):1483-90. PubMed ID: 20407444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes.
    Zhao J; Wang W; Huang Y; Wu J; Chen M; Cui P; Zhang W; Zhang Y
    DNA Cell Biol; 2014 Oct; 33(10):715-22. PubMed ID: 25050974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.
    He R; Yang L; Lin X; Chen X; Lin X; Wei F; Liang X; Luo Y; Wu Y; Gan T; Dang Y; Chen G
    Int J Clin Exp Pathol; 2015; 8(12):15632-41. PubMed ID: 26884832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
    Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX
    Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
    Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
    Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of astrocyte-elevated gene-1 in hepatocellular carcinoma (Review).
    Zhu HD; Liao JZ; He XX; Li PY
    Oncol Rep; 2015 Aug; 34(2):539-46. PubMed ID: 26035424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
    Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
    J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.